A PYMNTS Company

US: Merck announces latest push in pharma consolidation

By  |  December 8, 2014

Merck has announced its latest merger plans as the pharmaceutical consolidation spree continues.

According to reports, Merck is set to acquire Cubist Pharmaceuticals for $8.4 billion. The takeover would boost Merck’s operations in antibiotic research as the medical community focuses more on so-called “superbugs.”

Warnings from the World Health Organization have called for renewed collaboration to fight the rise in superbugs.

In a statement, Cubist said it is clear that Merck shares its “commitment to addressing the growing, global problem we are facing” regarding antibiotic resistance.

Full content: CSMonitor

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.